FTMT

Across TCGA pan-cancer cohorts, FTMT Mutation is linked to patient survival in 6 of 34 cancer types, making it a survival-associated FTMT data layer compared with 12 for mass-spec protein.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher FTMT Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated FTMT expression acts as an unfavorable survival marker.

READ, SKCM, and KICH are the cancer types where FTMT Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Median	III,IV	0.289	0.932	<.001	15	view →
SKCM	OS	Median	All	0.347	0.790	.002	15	view →
KICH	DFS	Median	All	0.102	0.848	.004	13	view →
DLBC	OS	Median	All	0.054	0.842	<.001	12	view →
COAD	OS	Median	All	0.380	0.806	<.001	12	view →
ESCA	OS	Median	All	0.211	0.876	.028	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

FTMT–READ (OS)

Open the READ breakdown →